Author/Authors :
Khazaei Poul Yalda نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran , Ziai Seyed Ali نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran , Zandi Ashkan نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Moini Zanjani Taraneh نويسنده Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Background: Glioblastoma multiforme, the most common, aggressive malignant
brain tumor which affects patients of all ages, is principally resistant to treatment.
Ciprofloxacin is an antibiotic that belongs to the fluoroquinolones. There are welldocumented
observations which indicate that ciprofloxacin has substantial
anti-proliferative, apoptotic, cytotoxic and oxidative stress activities on various tumor
cell lines.
Methods: We exposed the glioblastoma A-172 cell line to ciprofloxacin for 24, 48
and 72 h. Cytotoxicity was measured using MTT assay. The levels of Bax as an
apoptotic and Bcl-2 as an anti-apoptotic protein were measured by ELISA and oxidative
stress by the malondialdehyde assay.
Results: Ciprofloxacin induced tumor cell death in a dose-dependent manner with
an IC50 value of 259.3 ?M at 72 h. We observed an increase in Bax levels, a decrease
in Bcl-2 concentrations and increased Bax/Bcl-2 ratio under the influence of
ciprofloxacin. Malondialdehyde levels, as an important marker of oxidative stress,
increased in the human glioblastoma A-172 cell line.
Conclusion: These results indicated that ciprofloxacin had anti-tumor, cytotoxic and
apoptotic effects in the human glioblastoma A-172 cell line which might be useful as
an adjuvant added to a glioblastoma multiforme chemotherapeutic protocol in the future.